Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Top Indices
DJI
Nasdaq Composite
SPX
My Portfolio
United Therapeutic
(NQ:
UTHR
)
262.40
+4.27 (+1.65%)
Streaming Delayed Price
Updated: 4:00 PM EDT, May 3, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about United Therapeutic
< Previous
1
2
3
4
5
6
7
Next >
The Latest Analyst Ratings For United Therapeutics
May 02, 2024
Via
Benzinga
Lung Disease-Focused United Therapeutics Says It Is A Compelling Investment Opportunity
May 01, 2024
United Therapeutics impresses with record-breaking Q1 results. Revenue soars 34% Y/Y to $677.7 million, EPS jumps to $6.17. Tyvaso leads the charge with a 56% revenue surge.
Via
Benzinga
UTHR Stock Earnings: United Therapeutics Beats EPS, Beats Revenue for Q1 2024
May 01, 2024
UTHR stock results show that United Therapeutics beat analyst estimates for earnings per share and beat on revenue for the first quarter of 2024.
Via
InvestorPlace
Powell Industries Posts Upbeat Results, Joins A10 Networks, Garmin, DuPont And Other Big Stocks Moving Higher On Wednesday
May 01, 2024
Via
Benzinga
Beyond The Numbers: 4 Analysts Discuss United Therapeutics Stock
February 22, 2024
Via
Benzinga
Earnings Scheduled For February 21, 2024
February 21, 2024
Companies Reporting Before The Bell • Gatos Silver (NYSE:GATO) is estimated to report quarterly earnings at $0.09 per share on revenue of $83.00 million.
Via
Benzinga
Earnings Outlook For United Therapeutics
February 20, 2024
Via
Benzinga
United Therapeutics Corporation Reports First Quarter 2024 Financial Results
May 01, 2024
From
United Therapeutics Corporation
Via
Business Wire
CORRECTING and REPLACING PHOTO United Therapeutics Announces World’s First Successful Xenothymokidney Transplant
April 26, 2024
From
United Therapeutics Corporation
Via
Business Wire
United Therapeutics Corporation to Report First Quarter 2024 Financial Results Before the Market Opens on Wednesday, May 1, 2024
April 24, 2024
From
United Therapeutics Corporation
Via
Business Wire
NASDAQ:UTHR stands out as a stock that provides good value for the fundamentals it showcases.
April 24, 2024
Despite its impressive fundamentals, UNITED THERAPEUTICS CORP (NASDAQ:UTHR) remains undervalued.
Via
Chartmill
United Therapeutics to Feature Clinical Data Across its Commercial and Development Portfolio at the American Thoracic Society 2024 International Conference
April 16, 2024
From
United Therapeutics Corporation
Via
Business Wire
12 Health Care Stocks Moving In Tuesday's After-Market Session
March 26, 2024
Via
Benzinga
United Therapeutics Announces the First Comprehensive Review Publication on Xenotransplantation
March 26, 2024
From
United Therapeutics Corporation
Via
Business Wire
The Bargain Hunter’s Portfolio: 7 Smart Stock Buys for the Shrewd Investor
March 25, 2024
Although several companies have seen their valuations blossom, you can still find bargain stocks if you know where to look.
Via
InvestorPlace
United Therapeutics Corporation Announces $1 Billion Accelerated Share Repurchase Program
March 25, 2024
From
United Therapeutics Corporation
Via
Business Wire
The 3 Most Undervalued Nasdaq Stocks to Buy in March 2024
March 13, 2024
Learn about these undervalued NASDAQ stocks teeming with the potential to bounce back and show great returns for investors this year.
Via
InvestorPlace
Game Changers: 3 Biotech Stocks That Could Be Multibaggers in the Making
March 05, 2024
These three companies represent the world of biotech stocks and offer a unique blend of high risk and potentially high reward.
Via
InvestorPlace
United Therapeutics Corporation to Present at the Leerink Partners Global Biopharma Conference 2024
March 05, 2024
From
United Therapeutics Corporation
Via
Business Wire
United Therapeutics Corporation to Present at the TD Cowen 44th Annual Health Care Conference
February 27, 2024
From
United Therapeutics Corporation
Via
Business Wire
7 Under-the-Radar Biotech Stocks Gearing Up for Liftoff
February 26, 2024
Although the health innovation space can be a risky environment, undervalued biotech stocks can take some of the edge off.
Via
InvestorPlace
United Therapeutics' Challenges FDA Over Liquidia's Drug Approval Process, Clocks Strong Q4 Earnings
February 21, 2024
Legal battle unfolds as United Therapeutics challenges FDA's handling of Liquidia's drug approval process. Explore the implications on PH-ILD, potential 30-month stay, and recent financial...
Via
Benzinga
Exposures
Product Safety
United Therapeutics Corporation Reports Fourth Quarter and Full Year 2023 Financial Results
February 21, 2024
From
United Therapeutics Corporation
Via
Business Wire
United Therapeutics Commences Litigation to Ensure Fairness in the Drug Review Process
February 21, 2024
From
United Therapeutics Corporation
Via
Business Wire
This United Therapeutics Analyst Is No Longer Bearish, Expects Mid-Decade $4B Revenue Run Rate
February 12, 2024
United Therapeutics Corporation (NASDAQ: UTHR) is in a patent dispute with Liquidia Corp (NASDAQ:
Via
Benzinga
Topics
Intellectual Property
Exposures
Intellectual Property
Teva Pharmaceutical To Rally Around 58%? Here Are 10 Top Analyst Forecasts For Monday
February 12, 2024
Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades and downgrades, please see our analyst ratings page.
Via
Benzinga
Biotech Stocks Are on Fire: Here Are the Top 3 Picks for January
January 25, 2024
These biotech stocks offer exciting and disruptive solutions with the potential to expand to market caps worth trillions.
Via
InvestorPlace
Catalyst Countdown: 3 Biotech Stocks With Upcoming News That Could Move the Market
January 16, 2024
In the volatile world of biotech stocks, keeping an eye on the news is critical. Here are three companies to look out for.
Via
InvestorPlace
United Therapeutics Corporation to Present at the 42nd Annual J.P. Morgan Healthcare Conference
December 29, 2023
From
United Therapeutics Corporation
Via
Business Wire
Liquidia: Court victory the awakening of an industry giant?
December 27, 2023
Liquidia's stock surged after an enormous court win against United Therapeutics, accompanied by analyst upgrades and insider buying.
Via
MarketBeat
Topics
Intellectual Property
Exposures
Intellectual Property
< Previous
1
2
3
4
5
6
7
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.